Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.405 USD | +3.42% |
|
+26.28% | -48.64% |
09/07 | RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk | MT |
28/06 | Verve Therapeutics, Inc. Announces Board and Committee Appointments | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.64% | 601M | |
+22.15% | 46.56B | |
+45.15% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- RBC Cuts Price Target on Verve Therapeutics to $25 From $35, Keeps Outperform, Speculative Risk